Cargando…

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community

Detalles Bibliográficos
Autores principales:	Hivert, Virginie, Martin, Natalia, Hanauer, Marc, Aymé, Ségolène
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958415/ http://dx.doi.org/10.1186/1750-1172-5-S1-P25

Ejemplares similares

Rare diseases research in Europe: an overview based on data from the Orphanet database
por: Martin, Natalia, et al.
Publicado: (2010)

Orphanet Journal of Rare Diseases: Launch Editorial
por: Aymé, Ségolène, et al.
Publicado: (2006)

Rare diseases and disabilities: improving the information available with three Orphanet projects
por: de Chalendar, Myriam, et al.
Publicado: (2014)

Evolution of national and European policies in the field of rare diseases and their impact over the past five years
por: Rodwell, Charlotte, et al.
Publicado: (2014)

Clinical Practice Guidelines for Rare Diseases: The Orphanet Database
por: Pavan, Sonia, et al.
Publicado: (2017)

WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art
por: Aymé, Ségolène, et al.
Publicado: (2010)

The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
por: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
Publicado: (2014)

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
por: Nguengang Wakap, Stéphanie, et al.
Publicado: (2019)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

Classification of rare diseases: a worldwide effort to contribute to the International Classification of Diseases
por: Rath, Ana, et al.
Publicado: (2010)

Genetic testing in Europe: transborder testing is a necessity
por: Jovanovic, Mariana, et al.
Publicado: (2010)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases
por: Adjibi, Yolande, et al.
Publicado: (2010)

State of the art of services in Europe: where are the problems?
por: Aymé, Ségolène
Publicado: (2010)

Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
por: Giannuzzi, Viviana, et al.
Publicado: (2017)

Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
por: Hollak, Carla EM, et al.
Publicado: (2011)

Searching for rare diseases in PubMed: a blind comparison of Orphanet expert query and query based on terminological knowledge
por: Griffon, N., et al.
Publicado: (2016)

Go with the flow: de-orphaning focused combinatorial libraries
por: Reutlinger, Michael, et al.
Publicado: (2014)

State of the art of rare disease activities in Europe: a EUCERD perspective
por: Aymé, Ségolène
Publicado: (2012)

Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
por: Trieste, L, et al.
Publicado: (2015)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community
por: Aymé, Ségolène, et al.
Publicado: (2014)

The importance of review articles in making the voice of rare diseases heard: OJRD’s 10th anniversary
por: Aymé, Ségolène
Publicado: (2016)

Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
por: Pontes, Caridad, et al.
Publicado: (2018)

Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose
por: Thompson, G., et al.
Publicado: (2013)

Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation
por: Reker, Daniel, et al.
Publicado: (2014)

Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding
por: Aymé, Ségolène, et al.
Publicado: (2015)

http://www.euro-wabb.org: an EU Register for Alstrom, Bardet Biedl and other rare syndromes
por: Barrett, T, et al.
Publicado: (2012)

Editorial: Prevention, diagnosis and treatment of rare disorders
por: Cox, Timothy M., et al.
Publicado: (2022)

How to START? Four pillars to optimally begin your orphan drug development
por: Jonker, Anneliene Hechtelt, et al.
Publicado: (2023)

Is digital better?
por: Duncan, AA, et al.
Publicado: (2010)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data
por: Chazal, Pierre Etienne, et al.
Publicado: (2021)

Dendritic nonlinearities enable PFC microcircuits to serve as predictive modules of persistent activity
por: Papoutsi, Athanasia, et al.
Publicado: (2013)

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe
por: Ebbers, Hans C., et al.
Publicado: (2015)

EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation
por: Detela, Giulia, et al.
Publicado: (2019)

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
por: Cavaleri, Marco, et al.
Publicado: (2021)

Is faster always better?
por: Hamila, MA, et al.
Publicado: (2006)

GANIL authorised
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_4ncdodm3au3gveeaosvf9napt2